- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Enzon Pharmaceuticals Inc
+ Add to WatchlistENZN:US
3.1700 USD 0.0100 0.31%As of 20:10:00 ET on 05/17/2013.
Company Profile for Enzon Pharmaceuticals Inc (ENZN)
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.
Contact Information
Enzon Pharmaceuticals Inc
20 Kingsbridge Road
Piscataway, NJ 08854
United States
Phone: 1-732-980-4500
Key Executives for Enzon Pharmaceuticals Inc (ENZN)
| Ralph Del CampoChief Operating Officer | Andrew RackearChief Compliance Ofcr/Secy |
| Charles ConoverSenior VP:Research & Development | Timothy G DalyVP/Chief Acctg Ofcr/Controller |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page